Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F21%3A00075830" target="_blank" >RIV/65269705:_____/21:00075830 - isvavai.cz</a>
Result on the web
<a href="https://haematologica.org/article/view/haematol.2021.279174" target="_blank" >https://haematologica.org/article/view/haematol.2021.279174</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3324/haematol.2021.279174" target="_blank" >10.3324/haematol.2021.279174</a>
Alternative languages
Result language
angličtina
Original language name
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
Original language description
The impact of Oral-AZA on patient-reported fatigue and HRQoL, a key secondary endpoint in QUAZAR AML-001, was assessed using the self-administered Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale and EuroQoL EQ-5D-3L instruments. We hypothesized that Oral-AZA treatment would not meaningfully worsen fatigue or overall HRQoL from baseline, and that mean changes from baseline in fatigue and HRQoL scores in the Oral-AZA arm would be comparable (i.e., not inferior) to those in the placebo arm.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Haematologica
ISSN
0390-6078
e-ISSN
—
Volume of the periodical
106
Issue of the periodical within the volume
12
Country of publishing house
IT - ITALY
Number of pages
5
Pages from-to
3240-3244
UT code for WoS article
000732456400031
EID of the result in the Scopus database
2-s2.0-85120738327